Posted in Fun, Pharma, Pharma News, Pharmaceutical, Spoof on March 31, 2008 | No Comments »
Rumors have swirled around Behemoth Pharmaceuticals for months, but a press release has been scheduled for 10 am April 1st to announce the launch of PharmaBoost, a novel new treatment for Pharma Industry Negativity Syndrome (PINS).
“It’s been quite an ordeal getting this drug through FDA approval, and quite frankly, we were on pins and needles [...]
Posted in Boehringer Ingelheim, GSK, Glaxosmithkline, Merck, Novartis, Pharma, Pharma News, Pharmaceutical, Schering, Statins, Takeda, tagged actos, Altace, king pharmaceutical, lotrel, micardis, reliant pharmaceutical on March 31, 2008 | 1 Comment »
Novartis buying up Alcon - Novartis AG has agreed to buy Nestle AG’s 77 percent stake in U.S. company Alcon for $39 billion to boost its eye care business, the Swiss drugmaker said on Monday…more
Schering: the next cut is the deepest - Faced with a crushing blow to its top selling cholesterol medicine, Schering-Plough tonight [...]
Posted in Business, Consulting, Recommendations on March 31, 2008 | No Comments »
A short while ago, someone I respect in the sales training community asked me a question that took me aback for a moment - was it ethical for me to reach out to my community of readers and practitioners for recommendations?
You see, a major part of my practice here at Impactiviti is making recommendations - [...]
Posted in After Hours on March 29, 2008 | No Comments »
13 Fabulous Photos of a Rainy Day - tasty pix.
Earth at night - lights from cities, natural gas flares, fishing fleets, and wildfires. Breathtaking!
Are you Conversating?
Posted in Biotech, FDA, Friday Collection, Healthcare, Lilly, Marketing, Medicine, Merck, News, Pharma, Pharma News, Pharmaceutical, Sanofi-Aventis, Schering, Statins, Takeda, Wyeth, tagged Abilify, ACC, angiomax, cialis, Crestor, Humalog, Improve-It, Lantus, lunesta, Otsuka, prasugrel, singulair, vytorin on March 29, 2008 | No Comments »
Breaking news from the ACC:
Vytorin/Zetia gets panned - shows no benefit on the primary endpoint, though effective in reducing some markers. Doctors now wary and skeptical. Merck and Schering-Plough comment. Good summary with more links from Ed Silverman (Pharmlot blog - one of the best btw!) here.
Prasugrel gets a boost - The investigational antiplatelet [...]
Posted in Pharma News on March 29, 2008 | No Comments »
Can’t tell you any more now - you’ll have to be on pins and needles for a few more days…
Posted in Job, Job Board, Sales training, Training on March 27, 2008 | No Comments »
Two new open positions are now up on the Impactiviti Job Board:
Performance Consultant
Learning Architect (Pre-Sales)
Go and check them out! These 2 positions are with a training development/consulting company - there are also a number of Sales Trainer positions open with pharma companies.
Other job postings will be added in the next few days!
Posted in Meetings, Pharma, Pharmaceutical, SPBT, tagged carol wells, chris goins, david purdy, michael capaldi on March 26, 2008 | No Comments »
Did you know that 50% of the 2007 SPBT Annual Conference Attendees were first-timers? This is consistent with the general impression that many people take on a Training role as a building block for career development purposes. And this means that another transition is often on the horizon - from Trainer to [...]
Posted in Job Board, Pharmaceutical, Sales training, Training on March 24, 2008 | 1 Comment »
There are 8 new pharmaceutical sales training job openings added to the Impactiviti Job Board. Check it out!
(Current jobs listed are in NJ, Philly area, Long Island, Boston area, SF area, LA area, San Diego, Chicagoland, Georgia, Maryland)
Posted in Meetings, Novartis, Pharma, Pharmaceutical, SPBT, Sales training on March 24, 2008 | 1 Comment »
Have you ever wrestled with the decision about when to outsource a training project or need. And, to whom? And, how to go about it?
Of course you have. And very few people in sales training positions have been trained in how to go about project definition, vendor selection, writing up RFPs (Request for Proposal), etc.
What [...]
